| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/17/2008 | US20080090762 Epithelum-derived T-cell factor |
| 04/17/2008 | US20080090761 Method Comprising Nanofiltration to Obtain an Mbl Product Safe from Infectious Agents and the Product Obtainable by This Method |
| 04/17/2008 | US20080090757 Particularly Kahalalide F, a tridecapeptide with a ring shape side and a lateral side amidated with 5-methylhexanoic acid; 650 mu g/m2/day administered intravenously in cycles of 1-4 weeks; photosensitizing agent selected from methoxsalen, methotrexate, etretinate,corticosteroid, cyclosporine; nontoxic |
| 04/17/2008 | US20080090756 Somatostatin agonists |
| 04/17/2008 | US20080090755 Follistatin Variant Polypeptide |
| 04/17/2008 | US20080090750 N-terminal sequences of human growth hormone, human placental lactogen, human growth hormone variant hGH-V, and prolactin; used in inhibiting angiogenesis, antiproliferative, and in the diagnosis of diseases of human pregnancy involving abnormal placenta, preeclampsia and intrauterine growth retardation |
| 04/17/2008 | US20080090300 Such as the Abl tyrosine kinase domain; leukemia |
| 04/17/2008 | US20080090281 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080090260 Peptide sequence for use as substrate in bioassays which monitor aspartyl protease activity |
| 04/17/2008 | US20080090257 Compositions and methods for inhibiting or inducing adipogenesis |
| 04/17/2008 | US20080090251 Assays For Superantigens |
| 04/17/2008 | US20080090226 Novel Antigen Constructs Useful In the Detection and Differentiation of Antibodies to HIV |
| 04/17/2008 | US20080090222 Virus-Inactivated Hemoglobin And Method Of Producing The Same |
| 04/17/2008 | US20080089977 Peptide prepared by hydrolyzing soybean protein with an acidic or neutral enzyme from Aspergillus; possible to produce beers with rich beer flavor even at a malt extract concentration of 9 Brix or lower |
| 04/17/2008 | US20080089938 Compositions and methods for polynucleotide delivery |
| 04/17/2008 | US20080089929 Immunogenic fusion comprising transcription and negative factor domains for use in generation vaccine for prevention and treatment of viral infections; immunostimulants |
| 04/17/2008 | US20080089911 Borrelia burgdorferi outer surface protein ( OSP)C antigen and a second antigenic lipoprotein such as genetic engineered OSPA, or streptococcus pneumoniae cell surface protein ( PSPA) or both in same physio-chemical |
| 04/17/2008 | US20080089908 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 04/17/2008 | US20080089907 Modified vaccinia Ankara virus variant |
| 04/17/2008 | US20080089904 Clostridium toxin, and process for the preparation of immunogenic composition |
| 04/17/2008 | US20080089903 Cd4+t-lymphocyte-specific hepatitis c virus epitopes |
| 04/17/2008 | US20080089902 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 04/17/2008 | US20080089900 Identification of self and non-self antigens implicated in autoimmune disease |
| 04/17/2008 | US20080089899 Streptococcus pneumoniae proteins and nucleic |
| 04/17/2008 | US20080089897 ActRIIB Fusion Polypeptides and Uses Therefor |
| 04/17/2008 | US20080089895 Using antisense agents specific to lymphocyte membrane protein (TIRC7) as therapeutic tools in treatment and prevention of cell proliferative, vision and ischemic heart defects; wound healing agents |
| 04/17/2008 | US20080089888 Nucleotide sequences coding cancer/testis antigen for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 04/17/2008 | US20080089887 Members of the FC Receptor Homolog Gene Family (FcRH1-3,6) Related Reagents and Uses Thereof |
| 04/17/2008 | US20080089886 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/17/2008 | US20080089882 Novel Polypeptide Useful for Cancer Diagnosis and Treatment |
| 04/17/2008 | US20080089869 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 04/17/2008 | US20080089864 Viral sequences for targeted replication in tumor cells |
| 04/17/2008 | US20080089863 Non-Integrative And Non-Replicative Lentivirus , Preparation And Uses Thereof |
| 04/17/2008 | US20080089842 solid phase peptide synthesis for a peptidyl contrast agent; synthesizing an amino-chelator loaded resin coupling the loaded resin to C-terminus and/or backbone of a peptide, cleaving the amino-chelator-peptide from a resin, and chelating a lanthanide metal; DOTA or DTPA chelate coupled to peptide |
| 04/17/2008 | CA2673489A1 Inhibiting cyclin d polypeptides |
| 04/17/2008 | CA2666511A1 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and uses thereof |
| 04/17/2008 | CA2666344A1 Reconstituted surfactants having improved properties |
| 04/17/2008 | CA2666185A1 Influenza targets |
| 04/17/2008 | CA2665948A1 Reliable detection of vancomycin-intermediate staphylococcus aureus |
| 04/17/2008 | CA2665766A1 Process for generation of protein and uses thereof |
| 04/17/2008 | CA2665691A1 Agent for therapy and/or improvement of disseminated intravascular coagulation |
| 04/17/2008 | CA2665595A1 Glucoamylase variants with altered properties |
| 04/17/2008 | CA2665186A1 Stabilized therapeutic small helical antiviral peptides |
| 04/17/2008 | CA2665068A1 Methods for treating cancer with mva |
| 04/17/2008 | CA2664168A1 Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof |
| 04/17/2008 | CA2603132A1 Peptide inhibitors of cyclin-dependent kinase activity and uses thereof |
| 04/16/2008 | EP1912069A2 Method to screen ligands using eukaryotic cell display |
| 04/16/2008 | EP1911846A2 Genes which encode proteins for glucose-6-phosphate-dehydrogenase |
| 04/16/2008 | EP1911841A1 Methods for production of proteins |
| 04/16/2008 | EP1911789A1 Modified bio-related substance, process for producing the same, and intermediate |
| 04/16/2008 | EP1911788A1 Modified bio-related substance, process for producing the same, and intermediate |
| 04/16/2008 | EP1911767A2 Methods for producing immunoglobulins containing protection proteins in plants and their use |
| 04/16/2008 | EP1911765A2 Prevention, treatment and diagnosis of diseases associated with Beta-Amyloid formation and/or aggregation |
| 04/16/2008 | EP1911764A1 Growth-stimulating polypeptides for use in fish and crustaceans |
| 04/16/2008 | EP1911763A2 Compositions for the treatment of gastrointestinal disorders |
| 04/16/2008 | EP1911459A1 Lymphangiogenesis promoter |
| 04/16/2008 | EP1911458A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/16/2008 | EP1910842A2 A method for detecting peptides comprising a cross-beta structure |
| 04/16/2008 | EP1910837A2 Methods and compositions for diagnosis and treatment of influenza |
| 04/16/2008 | EP1910542A2 Compositions and methods of treating disease with fgfr fusion proteins |
| 04/16/2008 | EP1910539A2 Identification of jak/stat pathway modulating genes by genome wide rnai screening |
| 04/16/2008 | EP1910535A1 Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same |
| 04/16/2008 | EP1910521A1 Generation of antigen specific t cells |
| 04/16/2008 | EP1910418A1 Suppression of b-cell apoptosis in transgenic animals expressing humanized immunoglobulin |
| 04/16/2008 | EP1910417A2 Compounds |
| 04/16/2008 | EP1910416A1 Non-human animal model for cardiovascular disease characterized by a disrupted fibulin-4 gene |
| 04/16/2008 | EP1910414A2 Polynucleotides and polypeptides of the il-12 family of cytokines |
| 04/16/2008 | EP1910413A1 Method and system for in vitro protein folding |
| 04/16/2008 | EP1910412A2 Thaumatin from transgenic barley |
| 04/16/2008 | EP1910411A2 Guar protein extract product and method for the production and use thereof |
| 04/16/2008 | EP1910410A2 Tuberculosis antigen detection assays and vaccines |
| 04/16/2008 | EP1910409A2 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 04/16/2008 | EP1910408A2 Bifunctional protein anchors |
| 04/16/2008 | EP1910407A2 Mutated pseudomonas exotoxins with reduced antigenicity |
| 04/16/2008 | EP1910405A2 Complement c3a derived peptides and uses thereof |
| 04/16/2008 | EP1909895A2 Tandem cardiac pacemaker system |
| 04/16/2008 | EP1909815A2 Novel biologically active peptides and their new uses |
| 04/16/2008 | EP1909813A2 Peptidyl diacylglycerides |
| 04/16/2008 | EP1909778A1 Sensitization of immune system against haptenized melanoma antigens |
| 04/16/2008 | EP1909559A1 Management of plant pathogens |
| 04/16/2008 | EP1794591A4 Process for removing endogenous vitamin b12 and folate from albumin preparations |
| 04/16/2008 | EP1720995A4 Methods and compostions for targeted cleavage and recombination |
| 04/16/2008 | EP1720901A4 Polypeptide having function of cinnamyl alcohol dehydrogenase, a polynucleotide coding the polypeptide and those uses |
| 04/16/2008 | EP1660665B1 Chimaeric vector system |
| 04/16/2008 | EP1651673B1 Methods for use of an lkb1/strad/mo25 complex |
| 04/16/2008 | EP1585484A4 Hepatocyte growth factor variants |
| 04/16/2008 | EP1551762A4 Peptide derivatives, and their use for the synthesis of silicon-based composite materials |
| 04/16/2008 | EP1539820B1 Ostertagia vaccine |
| 04/16/2008 | EP1534334A4 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 04/16/2008 | EP1477560B1 ALGA-ORIGIN PROMOTER and INTRON |
| 04/16/2008 | EP1463542B8 Method for specifically immobilizing mediator molecules on substrate surfaces |
| 04/16/2008 | EP1385885B1 Fragments of the retinoic acid-related orphan receptor (ror) comprising the ligand binding domain (lbd), crystal structure of the lbd of ror-beta and their applications |
| 04/16/2008 | EP1309613B1 Pharmaceutical composition comprising an analgesic peptide |
| 04/16/2008 | EP1250434B1 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 04/16/2008 | EP1222289B1 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/16/2008 | EP1222283B1 Dna immunization against chlamydia infection |
| 04/16/2008 | EP1075491B1 Pth2 receptor selective compounds |
| 04/16/2008 | EP0984023B9 Cell surface molecule mediating cell adhesion and signal transmission |
| 04/16/2008 | EP0931093B1 Helicobacter pylori live vaccine |